NCT06640153Active, not recruiting
MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
Preoperative Evaluation of Resectability in Gastroesophageal Junction and Upper Gastric Adenocarcinoma Utilizing Multi-Parametric MRI and CT Imaging.
Source: ClinicalTrials.gov · Last updated 15 Oct 2024
Brief summary (registry, in English)
Accurate preoperative Siewert classification, precise assessment of the extent of esophageal involvement, and staging is crucial for determining the appropriate surgical approach and achieving negative resection margins. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and computed tomography (CT) in gastroesophageal junction and upper gastric cancers.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 7 Oct 2024
- Start date
- 21 Aug 2024
- Primary completion date
- 24 Aug 2025
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06640153
What you commit to
- Study type: Observational
- Planned participants: 100
- From 21 Aug 2024 to the primary completion date, 24 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- combined with other tumors;
- Clinical and imaging data were missing or could not meet the research needs;
- the location of lesions could not be determined;
Who the study is looking for
- patients with gastric cancer confirmed by preoperative gastroscopic biopsy;
- underwent standardized mpMRI and CT examination;
- patients with complete postoperative pathological data and pathological results of gastroesophageal Junction or upper gastric adenocarcinoma;
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital with Nanjing Medical University Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.